SCHEMBL5933091

SCHEMBL5933091

CCCCOc1cc2ccccc2cc1C(=O)[S]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 6/20 0.50
▸ CNR1 P21554 3/20 0.50
▸ TLR8 Q9NR97 3/20 0.49
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ NR1I2 O75469 1/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ ADRA2A P08913 1/20 0.47
▸ OPRK1 P41145 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ PPARG P37231 2/20 0.46
▸ PPARA Q07869 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4396853 0.86 CNR2 (0.51) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL7745987 0.86 ALDH1A1 (0.63) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL5861881 0.84 CNR2 (0.50) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL5861883 0.84 MEN1 (0.61) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL5933107 0.84 CNR2 (0.50) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL5862537 0.83 CNR2 (0.49) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL10769541 0.83 PTPN11 (0.60) CNR2CNR1MEN1KMT2ALMNA
SCHEMBL5862544 0.83 MEN1 (0.53) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL17961054 0.83 LMNA (0.57) CNR2CNR1TLR8MEN1KMT2A
SCHEMBL7740876 0.82 LMNA (0.56) CNR2CNR1TLR8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus MITSUI CHEMICALS, INC. (JP) 2006-04-27 — — US disclosed
EP-1484191-A1 REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE Sony Corporation (JP) 2004-12-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus ALPG, TRPC6, GNRHR CNR2 3509/4885CNR1 2630/4885TLR8 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback